Therapeutic integrin inhibition: Allosteric and activation-specific inhibition strategies may surpass the initial ligand-mimetic strategies
Ingo Ahrens, Karlheinz Peter
Baker Heart Research Institute, Melbourne, Australia
DOI
http://dx.doi.org/10.1160/TH08-03-0194